JESSICA MANCUSO: Open Payments
NPI 1437679834 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,456 in 132 payments from 18 companies in 2025. Trend: 2023 $2,409 · 2024 $2,017 · 2025 $2,456
Food & beverage: $2,456
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $365 |
| GENZYME CORPORATION | 12 | $354 |
| ABBVIE INC. | 25 | $342 |
| Janssen Biotech, Inc. | 5 | $233 |
| UCB, Inc. | 13 | $222 |
| PFIZER INC. | 8 | $206 |
| Novartis Pharmaceuticals Corporation | 34 | $193 |
| Amgen Inc. | 7 | $137 |
| Incyte Corporation | 4 | $88 |
| LEO Pharma Inc. | 3 | $78 |
Products named: DUPIXENT, EBGLYSS, TREMFYA, Bimzelx, CIBINQO, SKYRIZI, RINVOQ, OTEZLA.
Industry payments across NY — which companies pay providers there.
